Evidence map›Paper›PMID 27847869›Full record

ArticleScience advances2016

Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas.

Vania Vidimar, David Gius, Debabrata Chakravarti, Serdar E Bulun, Jian-Jun Wei, J Julie Kim

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. UTERINE FIBROIDS.Physiological reviews · 2025
    Review
  7. Review
  8. Body Mass Index and Uterine Fibroid Development: A Prospective Study.The Journal of clinical endocrinology and metabolism · 2024
    Article
  9. Article
  10. SomaticCells · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. High SPATA18 Expression and its Diagnostic and Prognostic Value in Clear Cell Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Vania VidimarDivision of Reproductive Science and Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60610, USA.
David GiusDepartment of Radiation Oncology, Northwestern University, Chicago, IL 60610, USA.
Debabrata ChakravartiDivision of Reproductive Science and Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60610, USA.ORCID 0000-0001-8446-8599
Serdar E BulunDivision of Reproductive Science and Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60610, USA.
Jian-Jun WeiDivision of Reproductive Science and Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60610, USA.; Department of Pathology, Northwestern University, Chicago, IL 60610, USA.
J Julie KimDivision of Reproductive Science and Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60610, USA.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
Uterine Leiomyoma Research Center ProgramP01HD057877 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BULUN, SERDAR E. · 2009 to 2019
$12.2M
Loss of mtSIRT3, Decreased MnSOD Activity, and IR Induced Genomic InstabilityR01CA152601 · NCI · VANDERBILT UNIVERSITY · PI BONINI, MARCELO G. · 2010 to 2019
$3.5M
SIRT3 is a Mitochondrial Tumor Suppressor in ER/PR Positive Mammary TumorsR01CA152799 · NCI · VANDERBILT UNIVERSITY · PI GIUS, DAVID · 2011 to 2015
$1.6M
NCI NIH HHS P30 CA060553NCI NIH HHS R01 CA152601NCI NIH HHS R01 CA152799NICHD NIH HHS P01 HD057877
6 · The paper itself

Abstract

AKT signaling promotes cell growth and survival and is often dysregulated via multiple mechanisms in different types of cancer, including uterine leiomyomas (ULMs). ULMs are highly prevalent fibrotic tumors that arise from the smooth muscular layer of the uterus, the myometrium (MM). ULMs pose a major public health issue because they can cause severe morbidity and poor pregnancy outcomes. ‬We investigate the mechanisms driving ULM growth and survival via aberrant activation of AKT. We demonstrate that an acetylation-mediated impairment of the manganese superoxide dismutase (MnSOD) activity is prevalent in ULM cells compared to the normal-matched MM from the same patients. This impairment increases the levels of superoxide and oxidative stress, which activate AKT via oxidative inactivation of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Redox activation of AKT promotes ULM cell survival under conditions of moderate but persistent oxidative stress that are compatible with ULM's prooxidative microenvironment. Moreover, because of impaired MnSOD activity, ULM cells are sensitive to high levels of reactive oxygen species (ROS) and superoxide-generating compounds, resulting in decreased ULM cell viability. On the contrary, MM cells with functional MnSOD are more resistant to high levels of oxidants. This study demonstrates a causative role of acetylation-mediated MnSOD dysfunction in activating prosurvival AKT signaling in ULMs. The specific AKT and redox states of ULM cells provide a potential novel therapeutic rationale to selectively target ULM cells because of their defective ROS-scavenging system.‬‬‬‬‬‬‬‬.

Indexed as

Signal TransductionTumor MicroenvironmentAdultCell SurvivalEnzyme ActivationFemaleHumansLeiomyomaMiddle AgedProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSuperoxide DismutaseProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanSuperoxide DismutaseAKTfibroidsleiomyomaMnSODROS

Identifiers

PMID27847869
PMCPMC5099990
OpenAlexW2547679397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.